THE USE OF LEVAN-ENHANCED DERMAL INFECTIONS IN RABBITS IN THE STUDY OF IN VIVO ACTIVITY OF ANTIBIOTIC SUBSTANCES.
D000900:Anti-Bacterial Agents; D003353:Corynebacterium diphtheriae; D003880:Dermatology; D003911:Dextrans; D004917:Erythromycin; D005630:Fructans; D007239:Infections; D010336:Pathology; D010400:Penicillin G; D010405:Penicillinase; D010600:Pharmacology; D011552:Pseudomonas Infections; D011817:Rabbits; D012106:Research; D012294:Rifamycins; D013203:Staphylococcal Infections; D013307:Streptomycin
D000900:Anti-Bacterial Agents; D003911:Dextrans; D005630:Fructans; D012294:Rifamycins; D004917:Erythromycin; C023808:rifamycin SV; D010405:Penicillinase; D010400:Penicillin G; D013307:Streptomycin
CORYNEBACTERIUM DIPHTHERIAE; DERMATOLOGY; DEXTRAN; ERYTHROMYCIN; EXPERIMENTAL LAB STUDY; INFECTION; PATHOLOGY; PENICILLIN G; PENICILLINASE; PHARMACOLOGY; PSEUDOMONAS INFECTIONS; RABBITS; RIFOMYCIN; STAPHYLOCOCCAL INFECTIONS; STREPTOMYCIN